Recent investigations with a mouse in vivo xenograft model further substantiated the inhibitory role of USF2 since overexpression of USF2 in prostate cancer cells inhibited the tumorigenicity of these cells (Chen et al., 2006). Here, USF2 is linked to prostate cancer.